About The Centre for Dermatology
Clinical Trials at The Centre for Dermatology
During the past decade, The Centre for Dermatology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 21 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Centre for Dermatology" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Dermira, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Centre for Dermatology"
#1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at The Centre for Dermatology
According to Clinical.Site data, the most researched conditions in "The Centre for Dermatology" are
"Atopic Dermatitis" (8 trials), "Plaque Psoriasis" (5 trials), "Psoriasis" (5 trials), "Acne Vulgaris" (4 trials) and "Dermatitis, Atopic" (3 trials). Many other conditions were trialed in "The Centre for Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at The Centre for Dermatology
Most popular intervention types in "The Centre for Dermatology" are "Drug" (31 trials), "Other" (5 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Lebrikizumab" (3 trials), "PF-06700841" (3 trials), "Abrocitinib 200 mg" (2 trials) and "Adalimumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Centre for Dermatology
The vast majority of trials in "The Centre for Dermatology" are
34 trials for "All" genders.
Clinical Trials Status at The Centre for Dermatology
Currently, there are NaN active trials in "The Centre for Dermatology".
undefined are not yet recruiting,
undefined are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in The Centre for Dermatology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Centre for Dermatology, 2 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".